BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37521428)

  • 1. The mirrored cationic peptide as miRNA vehicle for efficient lung cancer therapy.
    Xu W; Du L; Yu L; Cen H; Lin F; Wang S; Ruan Z; Lin Z; Zhang X; Zhou N; Chang J; Yu X; Zhang L; Liang L
    MedComm (2020); 2023 Aug; 4(4):e273. PubMed ID: 37521428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy.
    Liang L; Cen H; Huang J; Qin A; Xu W; Wang S; Chen Z; Tan L; Zhang Q; Yu X; Yang X; Zhang L
    Mol Cancer; 2022 Sep; 21(1):186. PubMed ID: 36171576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
    Su Y; Shetty A; Jiang F
    Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer.
    Peng J; Wang R; Sun W; Huang M; Wang R; Li Y; Wang P; Sun G; Xie S
    Biomater Sci; 2021 Sep; 9(19):6528-6541. PubMed ID: 34582541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-148a-3p Directly Targets SERPINE1 to Suppress EMT-Mediated Colon Adenocarcinoma Progression.
    Hu B; Chen Z; Wang X; Chen F; Song Z; Cao C
    Cancer Manag Res; 2021; 13():6349-6362. PubMed ID: 34408494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2.
    Cao X; Xue F; Chen H; Shen L; Yuan X; Yu Y; Zong Y; Zhong L; Huang F
    Ann Transl Med; 2022 Dec; 10(24):1374. PubMed ID: 36660663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-937-3p promotes metastasis and angiogenesis and is activated by MYC in lung adenocarcinoma.
    Ma Z; Chen G; Chen Y; Guo Z; Chai H; Tang Y; Zheng L; Wei K; Pan C; Ma Z; Xia Y; Zhang A
    Cancer Cell Int; 2022 Jan; 22(1):31. PubMed ID: 35033084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of miRNA-148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β-catenin signaling pathway via downregulating maternally expressed gene-3.
    Sun Y; Zhu Q; Zhou M; Yang W; Shi H; Shan Y; Zhang Q; Yu F
    Exp Ther Med; 2019 Jan; 17(1):639-648. PubMed ID: 30651845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
    Ashizawa M; Okayama H; Ishigame T; Thar Min AK; Saito K; Ujiie D; Murakami Y; Kikuchi T; Nakayama Y; Noda M; Tada T; Endo H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
    Mol Cancer Res; 2019 Jun; 17(6):1403-1413. PubMed ID: 30872332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the
    Li N; Li R; Song B; Ge H; Qu Y
    J Oncol; 2022; 2022():6883140. PubMed ID: 35646115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
    Li J; Gu X; Gao C; Zhang J
    Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
    Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA HOXA11-AS Promotes Non-Small Cell Lung Cancer Tumorigenesis Through microRNA-148a-3p/DNMT1 Regulatory Axis.
    Bai Y; Lang L; Zhao W; Niu R
    Onco Targets Ther; 2019; 12():11195-11206. PubMed ID: 31908486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-148a-3p Promotes Colorectal Cancer Cell Ferroptosis by Targeting SLC7A11.
    Martino E; Balestrieri A; Aragona F; Bifulco G; Mele L; Campanile G; Balestrieri ML; D'Onofrio N
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-148a-3p inhibits the proliferation of cervical cancer cells by regulating the expression levels of DNMT1 and UTF1.
    Chen Q; Wang Y; Dang H; Wu X
    Oncol Lett; 2021 Aug; 22(2):617. PubMed ID: 34257725
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.